Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 221-240 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 221 | Payload Aerospace, S.A. lowweak | Opp 2 Risk 3 | Thesis: Only weak opportunity support is visible in these reviewed sources: membership rationale says the company completed a €180M Series C fundraising, but no representative article, no direct positive evidence, and no in-recent evidence window article detail are provided here, so there is not enough cited support to form a strong 1 year+ opportunity thesis. Why now: Why now is weak because the reviewed sources' coverage debug shows zero article IDs after the March 29, 2026 cutoff and zero evidence after recent evidence window; any older fundraising context may no longer capture current business state. See support references listing article in the membership rationale, but no or article detail is provided in the reviewed sources, so recency and context cannot be independently assessed. Caveats: No -bearing article detail is provided for the fundraising support article, so factual claims beyond the membership rationale cannot be expanded. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0, limiting confidence. |
| 222 | Pilot Photonics lowweak | Opp 2 Risk 1 | Thesis: Membership rationale says Pilot Photonics secured a €1 million ESA contract for space photonics development and that the technology addresses satellite communication demands, which could support a modest long-horizon opportunity thesis if contract execution expands. Why now: Why now is limited because only membership rationale references article: and the reviewed sources provide no or retained evidence after recent evidence window. Caveats: The ESA contract claim cannot be elevated strongly without the underlying article or summary in the reviewed sources. Coverage data shows evidence after recent evidence window 0. Opportunity may be real, but reviewed sources support is too sparse for higher conviction. |
| 223 | Pixxel lowweak | Opp 2 Risk 1 | Thesis: Pixxel has a plausible long-horizon opportunity narrative from an external article summary describing a Pixxel-led consortium winning an Indian EO constellation PPP, but that article is dated October 13, 2025 and was dropped by the 90-day recent evidence window, so it cannot support a current ranking thesis. Why now: Why now is weak because the only cited article summary in the reviewed sources are outside the 90-day evidence window, October 13, 2025 Caveats: The representative article for Pixxel is outside the recent evidence window and evidence recent evidence review shows kept_rows 0. No retained structured positive or negative rows are available. |
| 224 | Reliance Industries Limited lowweak | Opp 2 Risk 2 | Thesis: There is a possible long-horizon opportunity if Reliance, via Jio Platforms, advances its described LEO satellite communications ambitions, but the reviewed sources does not retain representative article details, or within the recent evidence window evidence to ground that as a current high-conviction thesis. Why now: Why now is weak because although the phase-2 rationale references articles, and: regarding LEO satellite communication plans, no or retained evidence are available and coverage data shows articles after recent evidence window of 0. Caveats: Phase-2 rationale suggests planning activity, not confirmed operating status, and cannot be cited as fact without /evidence. No representative articles or evidence are available after recent evidence window. Scores are constrained by insufficient retained evidence, not by a definitive neutral business view. |
| 225 | Remondo lowweak | Opp 2 Risk 2 | Thesis: Older context suggests a potentially differentiated Earth-observation approach, with a first mission planned in 2027 to demonstrate a partial aperture imaging system, but this falls outside the active evidence recent evidence window and is insufficient for a strong current rank. Why now: The only concrete article summary is dated February 23, 2026 and therefore outside the 90-day recent evidence window cutoff of March 29, 2026; it says Remondo plans to launch its first mission in 2027 to demonstrate PAIS, which is interesting for long-horizon monitoring but not strong enough for a current thesis. Evidence
Caveats: All dated evidence was dropped by the 90-day recent evidence filter. Only one older article is available, so corroboration is limited. |
| 226 | Rhea Space Activity lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says Rhea Space Activity raised about $6 million in Series A financing for GPS-denied navigation software targeting military and intelligence customers, which would be a constructive long-horizon signal if confirmed by available evidence, but this screen contains no usable within the recent evidence window evidence or article. Why now: Why now is limited because no within the recent evidence window evidence were retained for ranking, so recency and durability cannot be tested. Caveats: Phase-2 membership rationale references, but no or available evidence row is provided in these reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The financing claim cannot be elevated beyond low conviction without direct available evidence. |
| 227 | Rocket One, Inc. lowweak | Opp 2 Risk 2 | Thesis: Among this screen, Rocket One has the strongest contextual indication of a strategic pivot toward space/defense AI chips and nano-launch or nanosatellite enablement, which could become a long-horizon opportunity if later corroborated by direct execution evidence. However, these reviewed sources have no direct positive evidence inside the recent evidence window, so the thesis remains weak. Why now: Membership rationale cites articles, and: describing a renamed former biotech company pivoting toward space/defense AI chips and nano-launch or nanosatellite enablement, but coverage data still shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. unavailable in reviewed sources. Caveats: Context suggests strategic intent, not proven execution. No article are provided for cited membership-rationale articles. No direct evidence survive recent evidence filtering. |
| 228 | Rogue Space Systems lowweak | Opp 2 Risk 1 | Thesis: There is limited relevance support that Rogue Space Systems is an operating in-orbit servicing company, which is directionally compatible with a long-horizon commercial space opportunity view, but the evidence is only undated directory-style context and not direct positive operating proof. Why now: The only retained evidence is an undated external sector page listing Rogue Space Systems as an operating in-orbit servicing company, so the why-now is weak and recency is uncertain. Evidence
Caveats: Evidence is undated and explicitly not recency proof per reviewed sources policy. Same-article repeated rows are not independent confirmation. No direct evidence of contracts, funding, milestones, or setbacks is included. |
| 229 | RTX Corporation lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources' membership rationale references involvement in U.S. Space Force and missile-warning programs, which could support long-horizon opportunity, but no within the recent evidence window direct evidence or representative article summaries are available for scoring in this screen. Why now: Although the membership rationale references articles, and: the reviewed sources loads zero reviewed evidence after recent evidence filtering, so there is no directly scorable current catalyst from local evidence. Caveats: Very large article universe exists, but article count is not conviction. Membership support references potentially meaningful articles, but those summaries/evidence are not available here and therefore cannot be elevated into direct scoring evidence. |
| 230 | Sanyark Space Technologies lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources places Sanyark Space Technologies in a spacetech accelerator among startups working on rocket propulsion, satellites, and space energy. That supports a possible early-stage opportunity setup, but the reviewed sources does not specify which activities belong to Sanyark itself and provides no direct evidence row or (: not provided in reviewed sources). Why now: There is no supported timing edge because the reviewed sources have zero direct evidence after recent evidence window and no dated article details beyond the structure. Caveats: Accelerator participation is weaker than company-specific funding or contract evidence. The article appears to describe a cohort rather than a company-specific event. No, quote, or direct event row is available. |
| 231 | Satellogic Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources membership rationale describes Satellogic as an Earth observation/geospatial company with constellation and monitoring contracts, which could be constructive over a 1 year+ horizon, but no available current evidence supports a stronger call. Why now: Why-now support is absent because coverage data shows zero evidence after recent evidence window. Caveats: Phase2 rationale cites 2026-04, and: but no representative articles or evidence are available for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects missing current reviewed sources evidence rather than negative evidence. |
| 232 | SatixFy lowweak | Opp 2 Risk 2 | Thesis: Phase-2 rationale references SatixFy as an Israeli chipmaker acquired by MDA Space with first space-grade chips shipped, which may indicate strategic relevance, but there are no retained in-window evidence here. Why now: The reviewed sources includes no representative article or evidence row inside the 90-day recent evidence window, so there is no dated near-current catalyst to anchor a 1 year+ view from this screen alone. Caveats: No retained evidence after recent evidence window. Referenced acquisition/shipment facts are only in the phase-2 rationale here, not in cited retained evidence. |
| 233 | SatSure Analytics India Pvt. Ltd. lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence context indicates SatSure is developing a large Earth Observation AI model and received IN-SPACe Technology Adoption Fund support including a ₹24.6 crore grant, which could support longer-horizon capability building, but no direct post-recent evidence window evidence are available to validate timing, scale, or current business momentum in the next 1 year+ horizon. Why now: There is no reliable 'why now' catalyst in the available evidence. The reviewed sources notes support/article IDs were used for membership, but after the 90-day recent evidence filter there were 0 article IDs after recent evidence window and 0 evidence available, so recency is uncertain for any thesis. Caveats: No direct evidence available after recent evidence window for this company. Membership rationale references article IDs, and: but the reviewed sources does not provide or article summaries for citation. Without -bearing evidence, factual support is limited to reviewed sources-level membership rationale only. |
| 234 | SatVu lowweak | Opp 2 Risk 1 | Thesis: An external article says SatVu closed a £30m funding round, which is positive financing context, but that article is dated February 17, 2026 and was dropped by the 90-day recent evidence policy, so it cannot support a strong current opportunity ranking Why now: There is no usable within the recent evidence window evidence after filtering; the only cited article is older than the March 29, 2026 cutoff and therefore not timely support for a 1 year+ ranking under these reviewed sources' evidence policy. Caveats: The reviewed sources report zero kept rows after recent evidence window for SatVu. Older funding evidence exists but was dropped by policy, so recency is insufficient for a stronger score. |
| 235 | Scale AI lowweak | Opp 2 Risk 1 | Thesis: Membership rationale says Scale AI received a U.S. Space Force Golden Dome contract as part of an approximately $3.2 billion award group, which, if current and durable, could support a meaningful public-sector space/defense opportunity over a 1 year+ horizon. Why now: Why now is muted because the reviewed sources references support article in membership rationale, but no, article summary, or retained evidence after the 90-day filter are available to confirm timing or scope. Caveats: Despite 273 articles considered, coverage data shows articles after recent evidence window 0 and evidence after recent evidence window 0. The contract claim is only present in membership rationale citing article without a in the served reviewed sources. Opportunity score is kept low because the the evidence standard require direct positive evidence, not just membership inclusion. |
| 236 | Schaeffler AG lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources rationale says Schaeffler planned a collaboration with Spire on satellite bus manufacturing and RF sensing, which suggests strategic adjacency to space systems, but there is no available within the recent evidence window direct evidence to underwrite a durable opportunity thesis. Why now: No surviving 90-day evidence are available despite 94 articles considered. The only support is the membership rationale reference to: but the reviewed sources provide no and no retained evidence. Caveats: Membership rationale is not sufficient directional proof. No direct positive or negative evidence survived the recent evidence window. Industrial-partner status versus core space-company status is unclear from the reviewed sources. |
| 237 | SEALCOIN AG lowweak | Opp 2 Risk 1 | Thesis: There is a hint of financing-related progress in space-based blockchain infrastructure, but the reviewed sources lack retained direct evidence strong enough to support a robust opportunity thesis. Why now: The membership rationale says SEALCOIN secured strategic investment for space-based blockchain infrastructure leveraging a satellite constellation, tied to article: but no or retained evidence are present after recent evidence window. Caveats: Only rationale-level description is available; no retained direct evidence row with is supplied. The business category fit is ambiguous in the reviewed sources itself. |
| 238 | Sidus Space Inc. lowweak | Opp 2 Risk 3 | Thesis: The membership rationale indicates Sidus Space operates LizzieSat satellites, manufacturing, and customer contracts, which could support a long-horizon operating-space-company thesis, but this screen includes no available within the recent evidence window article summaries or evidence to evaluate direction. Why now: Why now is weak because although the company had 44 considered articles, the reviewed sources show articles after recent evidence window = 0 and evidence after recent evidence window = 0, so the current business state is not evidenced here. Caveats: Phase-2 membership rationale references: and: but no or available evidence are provided. A large historical article universe should not be mistaken for conviction. No within the recent evidence window direct evidence is available for ranking. |
| 239 | Sift lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources hints at potential opportunity from Sift raising $42 million and building AI infrastructure for mission-critical hardware including space and defense, but no kept citable evidence or are provided here. Why now: Why now is weak because only article is referenced in the membership rationale, with no and no reviewed evidence to validate timing or materiality for the ranking horizon. Caveats: No article is available for article. Space exposure may be indirect rather than core. Coverage debug shows zero post-recent evidence window evidence. |
| 240 | Silicon Microgravity lowweak | Opp 2 Risk 2 | Thesis: There is modest theoretical opportunity because the reviewed sources' membership rationale says Silicon Microgravity received £500K in UK space funding, but no reviewed evidence row or citable article is supplied here. Why now: Why now is weak because the only support referenced is article: in the membership rationale, and the reviewed sources provide neither a nor a reviewed evidence row to substantiate timing beyond that summary. Caveats: No article is available for article Coverage debug shows zero post-recent evidence window evidence for ranking. Funding support alone, even if true, would not establish durable attractiveness without additional execution evidence. |
Risk view
Showing rows 301-320 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 301 | Hensoldt AG lowweak | Opp 1 Risk 1 | Thesis: There is no direct negative evidence in the reviewed sources after recent evidence window, so a material risk thesis is unsupported. Why now: No near-term or durable catalyst is established from the available evidence. Coverage debug shows 69 article IDs considered but 0 after recent evidence window and 0 evidence after dedupe. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Only context-level market-list mention is described, not a direct event or fact. |
| 302 | HEO USA lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available. The main risk is that the available evidence is too indirect to establish HEO USA's own operating momentum or strategic durability. Why now: Why now is weak because the cited technical-performance context is indirect, and the reviewed sources explicitly warns that relations are context-only and should not be used as counterparty propagation evidence. Caveats: No current evidence is provided for: and Counterparty/component context is not strong direct evidence for HEO USA itself. Zero evidence available after recent evidence window. |
| 303 | Hermeus Corporation lowweak | Opp 1 Risk 1 | Thesis: No direct adverse evidence is available, leaving no support for a material risk thesis other than evidence scarcity. Why now: There is no current timing signal from the reviewed sources. Coverage debug shows 29 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID, but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. The only described mention is indirect article context. |
| 304 | Hula Earth lowweak | Opp 3 Risk 1 | Thesis: No material adverse evidence is shown. Main risk is execution and classification ambiguity rather than documented negative business events. Why now: The only dated retained context is a Startup Intros profile with April 16, 2026, stating Hula Earth uses IoT sensors and satellite imagery and had raised €1.6 million in seed funding; that is recent enough for a 1 year+ watchlist but too weak for a high-conviction thesis. Evidence
Caveats: Evidence is weak context and supporting article context, not direct company event/facts. The funding itself is described as having occurred in November 2024 inside an April 16, 2026 profile, so exact recency of the financing event is older than the profile date. Reviewed evidence itself says Earth observation fit is plausible but not strong from these reviewed sources alone. |
| 305 | Impulso lowweak | Opp 1 Risk 1 | Thesis: No direct adverse evidence is available. The only risk is uncertainty from insufficient company-specific information. Why now: No timing catalyst is supported by the reviewed sources. Coverage debug shows 1 article considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Counterparty context cannot be propagated into a direct thesis. |
| 306 | Infinite Orbits lowweak | Opp 1 Risk 1 | Thesis: Main risk is evidentiary: there is insufficient recent company-specific evidence in the reviewed sources to validate business progress, customer traction, or execution status. Why now: There is no qualifying 90-day retained evidence. The only cited article mentioning Infinite Orbits is dated September 16, 2025, outside the reviewed sources' 90-day recent evidence window, so recency for any business progress is not established. Caveats: Reviewed evidence shows zero evidence retained after recent evidence window. Do not use the older TechCrunch article as current recency proof. Absence of recent negative evidence is not positive evidence. |
| 307 | Innoseis lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is provided. The main risk is evidentiary: the reviewed sources does not clearly establish business category fit, operating traction, or near-term durability. Why now: Potentially relevant because the article context references funding and lunar-measurement selection, but the reviewed sources provide no dated evidence or, so recency and sequence cannot be verified beyond the membership rationale tied to Caveats: No current evidence is provided for cited Zero evidence available after recent evidence window despite the membership rationale. Funding and technology-selection references are article-context level only here. |
| 308 | Integrate lowweak | Opp 1 Risk 1 | Thesis: No current material adverse thesis is supportable within the reviewed sources' retained recent evidence window evidence. Why now: Why now is weak because the only specific company article summary in the reviewed sources were dated February 23, 2026 and was dropped by the 90-day recent evidence window, so it cannot support current ranking despite mentioning financing and a Space Force contract, February 23, 2026). Caveats: The reviewed sources contain a representative article summary for stating Integrate 'closed a $17M Series A and landed a $25M space force contract to deploy secure program management software,' but the evidence recent evidence review says those rows were dropped as older than the March 29, 2026 cutoff, so they are not usable for current scoring. The company may be space-adjacent software rather than a direct space operator, per the reviewed sources' own membership rationale. |
| 309 | Integrated Launch Solutions, Inc. lowweak | Opp 1 Risk 1 | Thesis: No material negative thesis can be supported from retained evidence because the reviewed sources contain no direct negative rows within the recent evidence window. Why now: No current catalyst is evidenced in retained rows. Caveats: Phase-2 rationale says ILS provides engineering, mission design, range integration, and support for the STARLAUNCH pathway and cites: and: but neither summary nor is available here for citation. Coverage debug shows 7 articles considered and 0 after recent evidence window. Service-provider context alone is not directional proof without retained positive or negative evidence. |
| 310 | Integrity ISR lowweak | Opp 1 Risk 1 | Thesis: No material risk thesis can be supported because there is no retained direct negative evidence within the reviewed sources' recent evidence window. Why now: No current business change or catalyst is evidenced in the retained rows. Caveats: Phase-2 rationale references: about analysis of satellite maneuvers near an ICEYE satellite, but no or article summary is provided here for citation. Coverage debug shows 1 article considered and 0 after recent evidence window. Single-article descriptive context in phase-2 rationale is weaker than direct event/fact evidence and is uncitable here due to missing. |
| 311 | Intelsat lowweak | Opp 2 Risk 1 | Thesis: There is no material direct negative evidence in the reviewed sources. Main risk is evidence insufficiency rather than a documented adverse business development. Why now: Why now is weak because coverage data shows 0 article IDs after recent evidence window and 0 evidence available after recent evidence window, so timing and durability cannot be validated from these reviewed sources. Caveats: Membership rationale cites article IDs: and: but the reviewed sources provide no or summaries for them. Evidence recent evidence review shows kept_rows 0 and undated_rows_kept 0, so there is no usable direct evidence inside the ranking window. Cannot treat cohort membership as thesis attractiveness. |
| 312 | iQPS lowweak | Opp 2 Risk 1 | Thesis: No direct adverse evidence is present; the key risk is lack of retained post-recent evidence window evidence confirming launch cadence, financing, or customer demand. Why now: Why now is limited because the support is only referenced through membership rationale citing articles and, but the reviewed sources provide no or retained evidence after recent evidence window. Caveats: No or article summaries are provided for cited support articles and. Coverage data shows zero retained evidence after recent evidence window. Potentially interesting launch-agreement signal cannot be scored highly without direct reviewed sources evidence. |
| 313 | Island Green Capital lowweak | Opp 0 Risk 1 | Thesis: No direct adverse event is available, but evidence insufficiency and unresolved identity make it unsuitable for a directional opportunity call. Why now: No timing-based catalyst is supported because no post-recent evidence window evidence were available. Caveats: Phase2 rationale references article IDs: and: but no were provided in the reviewed sources. Reviewed evidence states summaries were about Molten Ventures and Isar Aerospace rather than clearly about Island Green Capital. Context-only mentions cannot support propagation. |
| 314 | Israel Aerospace Industries lowweak | Opp 1 Risk 1 | Thesis: No admissible direct negative evidence was available inside the 90-day recent evidence window, so there is no supportable adverse thesis from these reviewed sources alone. Why now: There is no usable current evidence in the reviewed sources for this company: evidence recent evidence review no current evidence was retained and coverage data shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale references article: but no company-specific evidence are available for ranking use. unavailable in reviewed sources. Caveats: Reviewed evidence provides no post-recent evidence window evidence. Membership rationale is not directional proof. Referenced: has no in the reviewed sources. |
| 315 | Karman Holdings Inc. lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is available. The primary risk is that the available context is too generic to prove durable space-specific positioning or a differentiated 1 year+ thesis. Why now: Why now is weak because there are no retained evidence after the 90-day cutoff date of March 29, 2026, despite multiple older considered articles. Caveats: No current evidence is provided for and. Revenue facts are referenced only in the membership rationale, not available as direct evidence. Broad supply-chain context is weaker than company-specific contract or product evidence. |
| 316 | Kepler Communications lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is available. The low risk score reflects missing evidence rather than a proven absence of business risk. Why now: There is no scoreable current catalyst because the reviewed sources contain no reviewed evidence after the 90-day recent evidence filter for this company. Caveats: Membership rationale cites, and, but the supporting article details are not available here. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. No current dated evidence means recency is uncertain. |
| 317 | Kessler Dynamics lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available in the reviewed sources after recent evidence filtering, but absence of evidence is not evidence of low risk; practical ranking risk is mostly informational opacity. Why now: There is no usable dated catalyst evidence in the reviewed sources for the 1 year+ horizon. The reviewed sources show 0 reviewed evidence after the 90-day cutoff and no representative article summary or for direct citation. Caveats: Coverage is effectively empty after recent evidence filtering: evidence recent evidence review shows kept_rows 0 and coverage data shows evidence after recent evidence window 0. The reviewed sources references support references including: but no or quote/summary is provided, so it cannot support factual claims under the citation rule. |
| 318 | KinetX lowweak | Opp 1 Risk 1 | Thesis: No direct negative evidence is available, so there is no supportable risk thesis from these reviewed sources alone. Why now: The only described context is that Intuitive Machines 'closed KinetX transaction' in article, but no business description, no, and no evidence are available after recent evidence filtering. Caveats: Acquisition context alone is not directional proof for KinetX. No company-specific operating facts are available. Referenced has no in the reviewed sources. |
| 319 | Kratos Defense & Security Solutions Inc. lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in the reviewed sources within the recent evidence window, so there is no grounded negative thesis beyond general uncertainty from lack of current evidence. Why now: Why now is weak because no article summaries or direct evidence were retained after the March 29, 2026 cutoff; recency is therefore insufficiently supported in these reviewed sources. Caveats: Membership rationale references support references and, but no article or retained evidence are provided, so they cannot be cited as factual support under the output rules. Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. |
| 320 | Kurs Orbital lowweak | Opp 2 Risk 1 | Thesis: Current reviewed sources evidence does not show material adverse developments; the main risk is evidentiary uncertainty rather than a documented company setback. Why now: The only retained evidence is an undated external sector index listing Kurs Orbital as operating in in-orbit servicing, so timing and recency are uncertain. Evidence
Caveats: Evidence is undated and the reviewed sources explicitly says undated external evidence is relevance context, not recency proof. Same-article repeated rows are not independent confirmation. No financing, contract, revenue, product milestone, or regulatory evidence is provided. |